08/05/2023
https://blog.gptools.org/2023/01/21/sickle-cell-lentiglobin/
Sickle cell cure with LentiGlobin | GP Tools Blog
LentiGlobin is a promising gene therapy for sickle cell disease, which is characterized by painful recurrence of vaso-occlusive events. A phase 1-2 study showed that one-time treatment with LentiGlobin resulted in sustained production of HbAT87Q in most red cells, leading to reduced hemolysis and co...
25/01/2019
A Viper Bite :
A Viper Bite | NEJM
Images in Clinical Medicine from The New England Journal of Medicine — A Viper Bite
30/11/2018
Low-cal diet offered on NHS:
Low-cal diabetes diet offered on NHS
A diet of soups and shakes that can reverse type 2 diabetes is to be trialled by the NHS in England.
23/11/2018
, city of lost hospitals :
London, city of lost hospitals | Wellcome Collection
Come on the trail of hundreds of ghost hospitals, whose remnants hold clues to medical treatments of the past.
16/11/2018
Letter to an aspiring Doctor :
Letter to an Aspiring Doctor | Theodore Dalrymple
You tell me you are thinking, my dear Stephen, of medicine as a career, but you wonder whether you . . . .
28/09/2018
After century of removing appendixes, find can be enough
Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis
During a 5-year follow-up of patients initially treated with antibiotics for uncomplicated acute appendicitis, this observational study assesses the rate of late recurrence.
11/09/2018
The app works with a simple press of a finger to the phone’s screen.
Blood pressure phone app could be a 'game-changer'
The built-in sensors and the camera work together to record pressure and blood flow.
23/08/2018
What happens when you spend a year using science to improve your brain:
What happens when you spend a year using science to improve your brain
How plastic is the brain?
22/08/2018
Risk Factors, Mortality, and Outcomes in Patients with Type 2 :
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Original Article from The New England Journal of Medicine — Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
10/08/2018
Why the Latest Alzheimer’s Drug Study Has So Many People Confused:
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
BAN2401, a new experimental Alzheimer’s medicine from Biogen and Eisai, raises more questions than it answers.